Jubilant Pharmova Board Approves Re-appointment of Priyavrat Bhartia and Arjun Shanker Bhartia
Jubilant Pharmova Limited announced that its Board of Directors approved the re-appointment of two key executives for extended terms. The board meeting was held on Friday, May 22, 2026, leading to the approval for the re-appointment of Mr. Priyavrat Bhartia as Managing Director and Mr. Arjun Shanker Bhartia as Joint Managing Director.The re-appointment for both individuals is effective from June 1, 2026, and for a further term of three years. The appointments remain subject to the subsequent approval of the Company’s Shareholders.
Re-appointment Details
The Board decision outlines the specific roles and tenure extensions for both directors.| Director | Role | Appointment/Re-appointment Date | Term Duration | Relationship |
|---|---|---|---|---|
| Priyavrat Bhartia | Managing Director | June 1, 2026 | 3 years | Son of Mr. Shyam Sunder Bhartia, Chairman |
| Arjun Shanker Bhartia | Joint Managing Director | June 1, 2026 | 3 years | Son of Mr. Hari Shanker Bhartia, Co-Chairman |
Professional Backgrounds
Mr. Priyavrat BhartiaMr. Priyavrat Bhartia, aged 49, possesses approximately 29 years of industry experience. He holds a Bachelor's Degree in Economics from Dartmouth College, USA, and a Master's in Business Administration from Stanford University, USA. He has served as a Non-Executive Director on the Board of Jubilant Pharmova Limited since May 2017 and was re-designated as Managing Director since June 2023.
Mr. Arjun Shanker Bhartia
Mr. Arjun Shanker Bhartia, aged 39, is a graduate of Brown University, Providence, RI, USA (2008). His professional career began as an Associate Consultant with Bain & Company between 2008 and 2010, providing him exposure across diverse industries in analytical and strategic roles. He has been associated with Jubilant Pharmova Limited since May 2017 as a Non-Executive Director and was re-designated as Joint Managing Director with effect from June 2023.
JUBLPHARMA Stock Price Movement
As of 3:09 PM, shares of Jubilant Pharmova Limited are shedding 0.53% in live trading, currently hovering near ₹1006.25. The stock is moving on significant interest, with 491,615 shares having been traded so far in the live market.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.